Restrictive agonist of toll-like receptor 3 (tlr3)

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) C12N 15/117 (2010.01) A61K 31/713 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2680134

A mismatched double-stranded ribonucleic acid, which is an agonist for Toll-like receptor 3 (TLR3), is used in vitro or in vivo as one or more of antiviral agent, antiproliferative agent, and immunostimulant. Methods of medical treat- ment and processes for manufacturing medicaments are provided.

Un acide ribonucléique double brin désapparié, qui est un agoniste du récepteur 3 de type Toll (TLR3), est utilisé in vitro ou in vivo en tant qu'agent antiviral, agent antiprolifératif et/ou immunostimulant. Des procédés de traitement médical et des processus de préparation de médicaments sont proposés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Restrictive agonist of toll-like receptor 3 (tlr3) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Restrictive agonist of toll-like receptor 3 (tlr3), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Restrictive agonist of toll-like receptor 3 (tlr3) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1777367

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.